ROSGQ — Rosetta Genomics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.23m
- $9.23m
Annual cashflow statement for Rosetta Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.5 | -12.9 | -14.5 | -17.3 | -16.2 |
| Depreciation | |||||
| Non-Cash Items | 2.45 | 1.2 | 0.864 | 2.47 | 1.42 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.906 | 0.795 | -0.239 | -2.81 | 3.54 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.64 | -10.6 | -13.6 | -16.9 | -10.4 |
| Capital Expenditures | -0.27 | -0.626 | -0.247 | -0.273 | -0.223 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.045 | -7.53 | -0.011 | 4.4 | 1.05 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.225 | -8.15 | -0.258 | 4.13 | 0.823 |
| Financing Cash Flow Items | 0 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.9 | 4.74 | 5.01 | 17.3 | 3.26 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.1 | -14 | -8.85 | 4.52 | -6.28 |